<DOC>
	<DOCNO>NCT00854932</DOCNO>
	<brief_summary>In neonate , clinical sign symptom associate early-onset sepsis non-specific currently available test poor positive negative predictive value . The investigator hypothesize procalcitonin ( PCT ) reliable negative predictive value allow reduction duration empiric antibiotic therapy suspect neonatal early-onset sepsis unchanged outcome . This study design multi-center , prospective , randomize intervention trial . The duration antibiotic therapy standard group base attend physician 's assessment probability infection hospitalisation . In PCT group , infection consider unlikely possible , antibiotic therapy discontinue two consecutive PCT value within normal range .</brief_summary>
	<brief_title>Neonatal Procalcitonin Intervention Study</brief_title>
	<detailed_description>Detailed description accord pilot study ( see reference ) . This trial design exclude difference rate re-infection death great 2 % . Assuming 2 % reinfection/death rate group , 770 patient required power 80 % alpha=0.05 . To allow unevaluable case 800 per group include . Based data pilot study ( see reference ) , number 770 per group difference mean antibiotic therapy duration 10 hour detect two-sided alpha 0.05 power 95 % .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>Term near term infant gestational age &gt; 34 week Suspected sepsis first 3 day life require empiric antibiotic therapy Parental consent Surgery first week life Severe congenital malformation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>procalcitonin</keyword>
	<keyword>sepsis</keyword>
	<keyword>newborn</keyword>
	<keyword>intervention study</keyword>
</DOC>